PhD, BSc (Hons I)
Sophie Stocker is a Senior Hospital Scientist in the Department of Clinical Pharmacology and Toxicology at St Vincent’s Hospital, Sydney. She is also a conjoint lecturer of the St Vincent’s Clinical School, University of New South Wales. Her research program involves clinical and experimental pharmacology, ethnopharmacology, pharmacogenomics, pharmacometrics and qualitative research on the impact of intrinsic and extrinsic factors on drug disposition, efficacy and safety. Her research focuses on understanding variability in response to medicines and how this can be managed to optimise patient care.
On the international front, Dr Sophie Stocker is a founding member of the inaugural Global Pharmacogenomics (PGx) Society, affiliated with the Pharmacogenomics Research Network (PGRN), and is on the Steering Committee for PGx implementation which aims to translate genetic research into routine clinical practice. She is a Co-Principal investigator for an international collaborative GWAS examining ‘The Genetic Determinates of Metformin Pharmacokinetics’. She is the International Association of Therapeutic Drug Monitoring and Clinical Toxicology Young Scientist Australian representative.
2018 St Vincent’s Campus Rising Star Award
2013 American Society for Clinical Pharmacology and Therapeutics, Presidential Trainee Award
2010 UCSF Post-doctoral Travel Grant
2009 Australian Society of Clinical and Experimental Pharmacology and Toxicology Annual Conference, Sydney, Australia. Percy Prize Winner
2008 Dean's award for most outstanding presentation, Faculty Postgraduate Conference, University of Sydney.
2008 Travel grant, Australasian Society of Clinical and Experimental Pharmacology and Toxicology
2007 Australian Pharmaceutical Science Association Conference Pharmaceutical Practice Best Poster
2007 Dean's award for most outstanding presentation, Faculty Postgraduate Conference, University of Sydney.
2007 Travel grant, Australasian Society of Clinical and Experimental Pharmacology and Toxicology
2006 - 2009 Australian Postgraduate Award
2006 "Dorothy Thorp Prize in Science Communication", University of Sydney
2006 Travel grant, Australasian Society of Clinical and Experimental Pharmacology and Toxicology
2019 St Vincent’s Clinic Foundation - SVPHS Ladies’ Committee Sister Mary Bernice Research Grant; “Vascular effects of the sodium-glucose cotransporter 2 inhibitor empagliflozin in people with type 2 diabetes and chronic kidney disease”; Day RO, Greenfield JR, Sevastos J, Stocker S, Samocha-Bonet D, Milder T; Award amount: $120,000
2018 St Vincent’s’ Curran Foundation Endowment Award; “Metabolomics of metformin in heart failure”; Carland JE, Stocker SL, Chowdhury G; Award amount: $35,000
2018 St Vincent’s’ Curran Foundation Endowment Award; “Optimising tacrolimus therapy in lung transplant patients”; Stocker SL, Carland JE; Award amount: $30,000
2017-18 The Friends of the Mater Foundation Grant Application; “Pharmacokinetic factors associated with scalp cooling efficacy for docetaxel-containing regimens in cancer patients”; Boyle F, Dear R, Andrews K, Carland JE, Stocker SL; Award amount: $20,000
2017 UNSW Research Infrastructure Scheme; “Installation of a Shimadzu Nexera X2 UHPLC into the Department of Clinical Pharmacology and Toxicology”; Day RO, Carland JE, Stocker SL, Norris RLG, Greenfield JR; Award amount: $78,431
2017 St Vincent’s Clinic Foundation Annual Research Grant; “The safety and pharmacokinetics of metformin in heart failure”; Day RO, Macdonald P, Greenfield J, Graham G, Carland J, Stocker S; Award amount: $30,000
2011 Young Investigator Pilot Award - NIH; “Effect of genetic variation in MATE1 and OCT3 transporters on the pharmacokinetics and pharmacodynamics of metformin in healthy African Americans”; Stocker SL, Dahlin A, Giacomini K; Award amount: $10,000